TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 2 | 1 | -3 | -5 | -13 | -26 | -13 | -10 |
| S | %wins | 50 | 100 | 100 | 100 | 100 | 100 | 92 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/22/10 17:30 | 3/18/10 | CVM | Cel Sci Corp | CO | Health | BioPrd | Biological Products, (No Diag | Kinsolving C Richard | VA | D | M.d | 12 | 0.2200 | 0 | 53 | 21 | 302 | D | 6 | 146 | -52 | -37 | 8 | 8 | -1 | 0 | 1 | -2 | -3 | -19 | -16 | -13 | |
3/22/10 17:30 | 3/18/10 | CVM | Cel Sci Corp | CO | Health | BioPrd | Biological Products, (No Diag | Kinsolving C Richard | VA | D | S.d | -37 | 0.7006 | 0 | -53 | -15 | 302 | D | 6 | 146 | -52 | -37 | 8 | 8 | -1 | 0 | 1 | -2 | -3 | -19 | -16 | -13 | |
2/22/05 17:16 | 2/17/05 | CVM | Cel Sci Corp | CO | Health | BioPrd | Biological Products, (No Diag | Kinsolving C Richard | VA | D | M.d | 6 | 0.2200 | 0 | 27 | 63 | 69 | D | 306 | -38 | 7 | 28 | 9 | -12 | -5 | 0 | 0 | -3 | -7 | -6 | -36 | -12 | |
2/22/05 17:16 | 2/17/05 | CVM | Cel Sci Corp | CO | Health | BioPrd | Biological Products, (No Diag | Kinsolving C Richard | VA | D | S.dm | -20 | 0.7400 | 0 | -27 | -28 | 69 | D | 306 | -38 | 7 | 28 | 9 | -12 | -5 | 0 | 0 | -3 | -7 | -6 | -36 | -12 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |